Welcome, Guest
Username: Password: Remember me
General
  • Page:
  • 1

TOPIC: Alopecia news on Cytori twitter

Alopecia news on Cytori twitter 25 Apr 2016 19:57 #6864

  • franshei
  • franshei's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 788
  • Thank you received: 102
30% enrollment mark reached and study continues.
The following user(s) said Thank You: mtpinman

Please Log in or Create an account to join the conversation.

Alopecia news on Cytori twitter 25 Apr 2016 23:38 #6865

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3238
  • Thank you received: 1101

franshei wrote: 30% enrollment mark reached and study continues.


Thanks-

Kerastem Hair Growth Clinical Trial Update
By: PR Newswire Association LLC. - 22 Apr 2016 Back to overview list

SAN DIEGO, April 22, 2016 /PRNewswire/ -- Kerastem Technologies today announced that its U.S. FDA approved Phase II STYLE trial, for male and female pattern baldness, has enrolled and treated its 21st patient (30% of target enrollment). In addition, as per the trial protocol, an independent data monitoring committee has reviewed safety data from the initial 10 patients and recommended that the study continue as planned. The 21 procedures performed at 4 trial sites in the United States, included fat harvest from small volume liposuction and scalp injections, were all completed successfully and well tolerated.

"We are very pleased by the study progress and the commitment of our study centers to the STYLE trial. In addition, we are encouraged that we have been able to demonstrate that same day fat harvest, cell processing and scalp injection is feasible and has been performed safely in multiple U.S. centers," said Dr. Eric Daniels, Chief Medical Officer, Kerastem Technologies.

STYLE is Kerastem's phase II randomized, blinded, and controlled investigation of Kerastem therapy in early stage female and male pattern baldness. STYLE is approved to enroll up to 70 patients at up to eight (8) centers within the United States. The trial is expected to completed enrollment later this year.

Details of the STYLE trial can be found at:

clinicaltrials.gov/ct2/show/NCT02503852?term=Kerastem&rank=1

Outside of the United States, the company is actively involved in market development, with Kerastem therapy currently being offered at a number of clinics in Europe & Japan. To learn more about Kerastem or the STYLE Clinical Trial, please visit www.kerastem.com .

Link: Kerastem News at Biotech Gate
The following user(s) said Thank You: mtpinman

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:
  • Page:
  • 1
Time to create page: 0.138 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites